Kristen Pierce Selected Research

2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- one

7/2016	A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer.
6/2014	Phase I study of PF-04691502, a small-molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kristen Pierce Research Topics

Disease

2	Diarrhea 07/2016 - 06/2007
2	Neoplasms (Cancer) 07/2016 - 06/2014
1	Dysgeusia (Parageusia) 07/2016
1	Fatigue 07/2016
1	Inflammation (Inflammations) 07/2016
1	Nausea 07/2016
1	Pneumonia (Pneumonitis) 07/2016
1	Vomiting 07/2016
1	Endometrial Neoplasms (Endometrial Cancer) 07/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2007
1	Exanthema (Rash) 06/2007

Drug/Important Bio-Agent (IBA)

2	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 07/2016 - 06/2014
1	StathminIBA 07/2016
1	gedatolisibIBA 07/2016
1	PlatinumIBA 07/2016
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	C-PeptideIBA 06/2014
1	Glucose (Dextrose)FDA LinkGeneric 06/2014
1	Insulin (Novolin)FDA Link 06/2014
1	3- (4- bromo- 2,6- difluorobenzyloxy)- 5- (3- (4- pyrrolidin- 1- ylbutyl)ureido)isothiazole- 4- carboxylic acid amideIBA 06/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2007
1	Carboplatin (JM8)FDA LinkGeneric 06/2007

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 07/2016 - 06/2007
1	Intravenous Infusions 07/2016